tafluprost

DRUG6 trials

Sponsors

Region Vaesterbotten, Santen Oy, Paolo Fogagnolo, Aristotle University Of Thessaloniki, Santen Pharmaceutical (Taiwan) Co., LTD

Conditions

GlaucomaGlaucoma, Primary Open AngleOcular HypertensionOcular Surface DiseaseOpen-Angle Glaucomaopen-angle and PEX glaucoma

Phase 3

Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops

CompletedNCT00596791

Santen OyOcular Hypertension, Open-Angle Glaucoma

Start: 2008-01-31End: 2008-08-31Target: 150Updated: 2009-01-12

Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops

CompletedNCT01087671

Santen OyOcular Hypertension, Open-Angle Glaucoma

Start: 2010-04-30End: 2010-10-31Updated: 2013-05-31

Switching From Preserved to Preserved-free Treatments for Glaucoma.

Paolo FogagnoloGlaucoma

Start: 2012-05-31End: 2014-06-30Target: 40Updated: 2014-05-16

Phase 4

24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy

CompletedNCT02802137

Aristotle University Of ThessalonikiGlaucoma, Ocular Surface Disease

Start: 2015-03-31End: 2016-01-31Updated: 2020-12-17

Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma

Active, not recruitingCTIS2023-510041-16-00

Region VaesterbottenGlaucoma, open-angle and PEX glaucoma

Start: 2013-04-22Target: 240Updated: 2024-05-16

Unknown Phase

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)

CompletedNCT04737928

Santen Pharmaceutical (Taiwan) Co., LTDGlaucoma, Primary Open Angle

Start: 2018-04-02End: 2019-01-22Updated: 2021-02-04

Related Papers

24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.

2016-12-0222 citations